Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: YU Wing Tak Wendy
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Ng Wang Yu Gary
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Rush Street Interactive, For: Jun 25 Filed by: WIERBICKI PAUL
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Cohen Ann
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 SOLITRON DEVICES INC For: Jun 24 Filed by: Olesen Value Fund L.P.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form SCHEDULE 13D/A PRO DEX INC Filed by: Swenson Nicholas John
-
Form 4 POWELL INDUSTRIES INC For: Jun 25 Filed by: POWELL THOMAS W
-
Form MA-I Bradley Payne LLC
-
Form MA-I/A Bradley Payne LLC
-
Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Patrick Kristin
-
Form X-17A-5 J.H. DARBIE & CO., INC. For: Mar 31
-
Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Shahbazi Hamed
-
Form MA-I/A Terminus Municipal Advis
-
Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Rubin Steven D
-
Form 4 Airbnb, Inc. For: Jun 24 Filed by: Blecharczyk Nathan
-
Form MA-I/A Cedar Creek Municipal
-
Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Jaksch Frank L Jr
-
Form 144 Braze, Inc. Filed by: Winkles Isabelle
-
Form SCHEDULE 13G Teamshares Inc Filed by: Spark Capital Growth Fund III, L.P.
-
Form 4 American Healthcare REIT For: Jun 24 Filed by: Foster Mark E.
-
Form 144 IONIS PHARMACEUTICALS Filed by: Baroldi Mariana
-
Form 144 IONIS PHARMACEUTICALS Filed by: O'NEIL PATRICK R.
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Miralles Gines Diego
-
Form 4 Enovix Corp For: Jun 24 Filed by: Chakravarthy Arthi
-
Form 144 Fidelity National Financ Filed by: SADOWSKI PETER T
-
Form 4 Asana, Inc. For: Jun 24 Filed by: Megji Aziz
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Lyons-Williams Lori
-
Form SCHEDULE 13G/A WaterBridge Infrastructu Filed by: WBR Holdings LLC
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Ware Olivia C
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Schimmelpennink Evert B.
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Ignelzi Troy A.
-
Form 144 IONIS PHARMACEUTICALS Filed by: Schneider Eugene
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Brady Todd R.
-
Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Boyce Sarah
-
Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 4 Dream Finders Homes, For: Jun 24 Filed by: Lovett William Radford II
-
Form 144 COMMUNITY FINANCIAL SYST Filed by: Bolus Mark J.
-
Form 4 CROSS TIMBERS ROYALTY For: Jun 24 Filed by: SoftVest GP I, LLC
-
Form 4 American Healthcare REIT For: Jun 24 Filed by: Richardson Valerie
-
Form 424B3 SharonAI Holdings Inc.
-
Form 4 American Healthcare REIT For: Jun 24 Filed by: O'Quinn Marvin R
-
Form 424B3 SharonAI Holdings Inc.
-
Form 4 Vinci Compass Investment For: Jun 24 Filed by: Ribeiro Sergio Passos
-
Form 10-Q Limitless X Holdings For: Mar 31
-
Form D 3B1 Corocoro Fund, LP
-
Form 8-K Outlook Therapeutics, For: Jun 26
-
Form 424B3 SharonAI Holdings Inc.
-
Form 8-K LGL GROUP INC For: Jun 26
-
Form DEFA14A Vaxart, Inc.
-
Form 424B2 CITIGROUP INC
-
Form 485BPOS LINCOLN NEW YORK ACCOUNT
-
Form D/A INSight Capital, LLC
-
Form 144 SEI INVESTMENTS CO Filed by: WEST ALFRED P JR
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K Graf Global Corp. For: Jun 26
